Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study

In conclusion, TPN is effective as a first-line treatment for patients with unresectable and metastatic ESCC. In addition, TPN treatment with sequential radiation might improve survival in patients with limited or oligo lymph node metastases.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Xiaodong Zhang, Jun Jia, Ming Lu, Xicheng Wang, Jifang Gong, Jie Li, Jian Li, Yan Li, Xiaotian Zhang, Zhihao Lu, Jun Zhou, Jing Yu, Zhiwei Sun, Ying Yang, Chuanling Liu, Yanjie Xiao, Lin Shen Tags: Research Paper Source Type: research